Walleye Capital’s Idexx Laboratories IDXX Stock Holding History

Walleye Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$169K	Sell	300 -1,000	-77%	-$641K	﹤0.01%	3433
2025 Q4	$879K	Sell	1,300 -2,800	-68%	-$1.91M	﹤0.01%	2548
2025 Q3	$2.62M	Buy	+4,100	New	+$2.49M	0.01%	1377
2025 Q2	–	Sell	-1,100	Closed	-$462K	–	4727
2025 Q1	$462K	Sell	1,100 -1,400	-56%	-$608K	﹤0.01%	2627
2024 Q4	$1.03M	Sell	2,500 -13,300	-84%	-$5.83M	﹤0.01%	2365
2024 Q3	$7.98M	Buy	15,800 +1,600	+11%	+$777K	0.02%	831
2024 Q2	$6.92M	Sell	14,200 -6,600	-32%	-$3.31M	0.01%	1031
2024 Q1	$11.2M	Buy	20,800 +15,700	+308%	+$8.58M	0.02%	766
2023 Q4	$2.83M	Buy	5,100 +2,900	+132%	+$1.36M	0.01%	1521
2023 Q3	$962K	Buy	+2,200	New	+$1.1M	﹤0.01%	2282
2023 Q2	–	Sell	-100	Closed	-$50K	–	4556
2023 Q1	$50K	Sell	100 -400	-80%	-$191K	﹤0.01%	3208
2022 Q4	$204K	Buy	+500	New	+$194K	﹤0.01%	2036

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Capital's IDXX Position: Q1 2026 in Review

Walleye Capital reduced its Idexx Laboratories (IDXX) stake by 99% in Q1 2026, selling an estimated $8.5M and leaving 170 shares worth $95.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3692.

Walleye Capital first reported a position in IDXX in Q3 2021 and has held it in 12 quarters since. The position peaked at $15.6M in Q3 2024. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Walleye Capital held 170 shares of Idexx Laboratories worth $95.5K as of Q1 2026.
Walleye Capital sold 13,261 Idexx Laboratories shares in Q1 2026, an estimated $8.5M.
Idexx Laboratories made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3692 holding.
Walleye Capital first reported a position in Idexx Laboratories in Q3 2021 and has held it in 12 quarters since.
Walleye Capital's Idexx Laboratories position peaked at $15.6M in Q3 2024.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.